---
title: BCAT1 regulates glioblastoma cell plasticity and contributes to immunosuppression
date: '2023-09-28'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37769206/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230929180838&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Glioblastoma is the most common malignant brain tumor in adults. Cellular
  plasticity and the poorly differentiated features result in a fast relapse of the
  tumors following treatment. Moreover, the immunosuppressive microenvironment proved
  to be a major obstacle to immunotherapeutic approaches. Branched-chain amino acid
  transaminase 1 (BCAT1) is a metabolic enzyme that converts branched-chain amino
  acids into branched-chain keto acids, depleting cellular α-ketoglutarate and producing
  ...
disable_comments: true
---
Glioblastoma is the most common malignant brain tumor in adults. Cellular plasticity and the poorly differentiated features result in a fast relapse of the tumors following treatment. Moreover, the immunosuppressive microenvironment proved to be a major obstacle to immunotherapeutic approaches. Branched-chain amino acid transaminase 1 (BCAT1) is a metabolic enzyme that converts branched-chain amino acids into branched-chain keto acids, depleting cellular α-ketoglutarate and producing ...